Cargando…
Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
Third-generation intravenous (i.v.) iron preparations are safe and efficacious and are increasingly used in the treatment of iron-deficiency anaemia. Hypophosphataemia is emerging as an established side-effect following the administration of certain compounds. Symptoms of hypophosphataemia can be ma...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioExcel Publishing Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819638/ https://www.ncbi.nlm.nih.gov/pubmed/33519940 http://dx.doi.org/10.7573/dic.2020-11-3 |